Author

K. Hui

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

HALP score in solid tumors: Prognostic value, heterogeneity, and translational considerations

Highlights • HALP integrates anemia, nutrition, immunity, and systemic inflammation.• Low HALP is generally linked to poorer outcomes across solid tumors.• Cutoff heterogeneity limits threshold transferability and clinical use.• Prospective validation is required before routine implementation.

Zian Jin, Chang-Hong Dong, K. Hui et al. · Translational Oncology · 0 citations

Sep 2026

The PTTG1/AURKA Axis Drives Acquired Anlotinib Resistance in Non-Small Cell Lung Cancer by Remodeling the Tumor Immune Microenvironment.

PTTG1 has been implicated in tumor progression and drug resistance, but its role in acquired anlotinib resistance in non-small cell lung cancer (NSCLC) remains unclear. This study investigated whether PTTG1 contributes to resistance and immune remodeling in NSCLC. We analyzed peripheral blood from NSCLC patients collec...

K. Hui, Yong-Hua Tan, Jia-Wei Song et al. · Biofactors · 0 citations